Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -73 | -63 | -186 | -125 | -92 |
| Depreciation Amortization | 0 | 0 | 4 | 4 | 4 |
| Accounts receivable | 1 | -1 | 1 | 1 | 1 |
| Accounts payable and accrued liabilities | 1 | -1 | 4 | -52 | 2 |
| Other Working Capital | 79 | 36 | 152 | 54 | 71 |
| Other Operating Activity | -50 | 2 | -56 | 50 | -38 |
| Operating Cash Flow | $-43 | $-27 | $-82 | $-67 | $-52 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-2 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -3 | -1 | -4 | -3 | -1 |
| Other Financing Activity | 50 | 30 | 84 | 69 | 51 |
| Financing Cash Flow | $47 | $29 | $80 | $66 | $50 |
| Beginning Cash Position | 0 | 0 | 2 | 2 | 2 |
| End Cash Position | 3 | 2 | 0 | 1 | 0 |
| Net Cash Flow | $3 | $2 | $-2 | $-1 | $-2 |
| Free Cash Flow | |||||
| Operating Cash Flow | -43 | -27 | -82 | -67 | -52 |
| Capital Expenditure | -2 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -44 | -27 | -82 | -67 | -52 |